PEANUTA heart failure drug and a vaccine against peanut allergies will be developed in Melbourne by new biotech companies.

To ensure the projects remains in the hands of the Victorian research institutes, a $9 million investment will be announced to fund start-up companies.

It is a major step for the country’s scientists who have struggled to gain financial support for their projects and research.

Following years of investigation the vaccine against peanut allergies will receive $4.85 million from the allocated funds to boost its development.

According to Professor Robyn O’Hehir the vaccine will use safe fragments of the peanut protein to potentially cure the condition.

Meanwhile, a drug which intends to extend the quality of life for heart-failure patients is also being developed in Melbourne.

The medication, which can be taken at home, targets late-stage heart disease symptoms including shortness of breath, fluid build-up and exercise intolerance.

For the full article: Ten Eyewitness News



Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s